1. Home
  2. VTOL vs RCUS Comparison

VTOL vs RCUS Comparison

Compare VTOL & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bristow Group Inc.

VTOL

Bristow Group Inc.

HOLD

Current Price

$37.08

Market Cap

1.1B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.61

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTOL
RCUS
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
3.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
VTOL
RCUS
Price
$37.08
$21.61
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$29.38
AVG Volume (30 Days)
172.7K
2.0M
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
148.42
N/A
EPS
4.78
N/A
Revenue
$1,466,774,000.00
$240,000,000.00
Revenue This Year
$8.09
N/A
Revenue Next Year
$8.76
N/A
P/E Ratio
$7.83
N/A
Revenue Growth
2.95
N/A
52 Week Low
$25.11
$6.50
52 Week High
$42.89
$26.40

Technical Indicators

Market Signals
Indicator
VTOL
RCUS
Relative Strength Index (RSI) 48.15 43.57
Support Level $35.90 $24.75
Resistance Level $37.91 $26.10
Average True Range (ATR) 1.03 1.50
MACD 0.04 -0.41
Stochastic Oscillator 51.93 21.97

Price Performance

Historical Comparison
VTOL
RCUS

About VTOL Bristow Group Inc.

Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: